Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Islet Autoantibodies.
Lampasona V, Liberati D. Lampasona V, et al. Among authors: liberati d. Curr Diab Rep. 2016 Jun;16(6):53. doi: 10.1007/s11892-016-0738-2. Curr Diab Rep. 2016. PMID: 27112957 Review.
The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.
Wyatt RC, Brigatti C, Liberati D, Grace SL, Gillard BT, Long AE, Marzinotto I, Shoemark DK, Chandler KA, Achenbach P, Gillespie KM, Piemonti L, Lampasona V, Williams AJK. Wyatt RC, et al. Among authors: liberati d. Diabet Med. 2018 Jul;35(7):954-963. doi: 10.1111/dme.13628. Epub 2018 Apr 19. Diabet Med. 2018. PMID: 29577424
Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes.
McLaughlin KA, Richardson CC, Ravishankar A, Brigatti C, Liberati D, Lampasona V, Piemonti L, Morgan D, Feltbower RG, Christie MR. McLaughlin KA, et al. Among authors: liberati d. Diabetes. 2016 Jun;65(6):1690-8. doi: 10.2337/db15-1058. Epub 2016 Mar 7. Diabetes. 2016. PMID: 26953162 Free article.
A novel LIPS assay for insulin autoantibodies.
Liberati D, Wyatt RC, Brigatti C, Marzinotto I, Ferrari M, Bazzigaluppi E, Bosi E, Gillard BT, Gillespie KM, Gorus F, Weets I, Balti E, Piemonti L, Achenbach P, Williams AJK, Lampasona V. Liberati D, et al. Acta Diabetol. 2018 Mar;55(3):263-270. doi: 10.1007/s00592-017-1082-y. Epub 2018 Jan 5. Acta Diabetol. 2018. PMID: 29305766
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial.
Reni M, Dugnani E, Cereda S, Belli C, Balzano G, Nicoletti R, Liberati D, Pasquale V, Scavini M, Maggiora P, Sordi V, Lampasona V, Ceraulo D, Di Terlizzi G, Doglioni C, Falconi M, Piemonti L. Reni M, et al. Among authors: liberati d. Clin Cancer Res. 2016 Mar 1;22(5):1076-85. doi: 10.1158/1078-0432.CCR-15-1722. Epub 2015 Oct 12. Clin Cancer Res. 2016. PMID: 26459175 Clinical Trial.
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
Dugnani E, Sordi V, Pellegrini S, Chimienti R, Marzinotto I, Pasquale V, Liberati D, Balzano G, Doglioni C, Reni M, Gandolfi A, Falconi M, Lampasona V, Piemonti L. Dugnani E, et al. Among authors: liberati d. Pancreatology. 2018 Dec;18(8):945-953. doi: 10.1016/j.pan.2018.09.006. Epub 2018 Sep 25. Pancreatology. 2018. PMID: 30293872
CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice.
Citro A, Valle A, Cantarelli E, Mercalli A, Pellegrini S, Liberati D, Daffonchio L, Kastsiuchenka O, Ruffini PA, Battaglia M, Allegretti M, Piemonti L. Citro A, et al. Among authors: liberati d. Diabetes. 2015 Apr;64(4):1329-40. doi: 10.2337/db14-0443. Epub 2014 Oct 14. Diabetes. 2015. PMID: 25315007
142 results